Impact of prior use of topical hemostatic agents on trial of labor after cesarean: Insights from a multicenter cohort study
International Journal of Gynecology & Obstetrics · 2024
DOI: 10.1002/ijgo.15089 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift International Journal of Gynecology & Obstetrics, 2024. Verfasst von Romi Levy und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Military Medicine and "Tzameret," Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel. Hauptthemen laut MEDLINE: Vaginal Birth after Cesarean, Uterine Rupture. Die Arbeit nennt 35 Literaturangaben.
Abstract (Originalsprache)
Objective
To evaluate the association between a topical hemostatic agent used at the time of cesarean delivery and uterine scar disruption (rupture or dehiscence) at the subsequent trial of labor after cesarean (TOLAC).
Methods
A multicenter retrospective cohort study was conducted (2005–2021). Parturients with a singleton pregnancy in whom a topical hemostatic agent was placed during the primary cesarean delivery were compared with patients in whom no such agent was placed. We assessed the uterine scar disruption rate after the subsequent TOLAC and the rate of adverse maternal outcomes. Univariate analyses were followed by multivariate analysis (adjusted odds ratio [aOR]; 95% confidence interval [CI]).
Results
During the study period, 7199 women underwent a trial of labor and were eligible for the study; 430 (6.0%) had prior use of a hemostatic agent, 6769 (94.0%) did not. In univariate analysis, a history of topical hemostatic agent use was not found to be significantly associated with uterine scar rupture, dehiscence, or failed trial of labor. This was also confirmed on multivariate analysis for uterine rupture (aOR 1.91, 95% CI 0.66–5.54; P = 0.23), dehiscence of uterine scar (aOR 1.62, 95% CI 0.56–4.68; P = 0.37), and TOLAC failure (aOR 1.08, 95% CI 0.79–1.48; P = 0.61).
Conclusion
A history of hemostatic agent use is not associated with an increased risk for uterine scar disruption after subsequent TOLAC. Further prospective studies in other settings are needed to strengthen these findings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Military Medicine and "Tzameret," Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
- Medical Corps, Israel Defense Forces, Israel.
- Department of Obstetrics and Gynecology, Shaare Zedek Medical Center, Affiliated with the Hebrew University School of Medicine, Jerusalem, Israel.
- Department of Obstetrics and Gynecology, McMaster University Medical Center, McMaster University, Hamilton, Ontario, Canada.
- Department of Nursing, Jerusalem College of Technology, Jerusalem, Israel.
ORCID-Profile: Reut Rotem
Zitieren
APA
Levy, R., Sela, H. Y., Weiss, A., Rotem, R., Grisaru-Granovsky, S., & Rottenstreich, M. (2024). Impact of prior use of topical hemostatic agents on trial of labor after cesarean: Insights from a multicenter cohort study. International Journal of Gynecology & Obstetrics. https://doi.org/10.1002/ijgo.15089
Vancouver
Levy R, Sela HY, Weiss A, Rotem R, Grisaru-Granovsky S, Rottenstreich M. Impact of prior use of topical hemostatic agents on trial of labor after cesarean: Insights from a multicenter cohort study. International Journal of Gynecology & Obstetrics. 2024. doi:10.1002/ijgo.15089
BibTeX
@article{Levy2024,
author = {Levy, Romi and Sela, Hen Y and Weiss, Ari and Rotem, Reut and Grisaru-Granovsky, Sorina and Rottenstreich, Misgav},
title = {Impact of prior use of topical hemostatic agents on trial of labor after cesarean: Insights from a multicenter cohort study},
journal = {International Journal of Gynecology & Obstetrics},
year = {2024},
doi = {10.1002/ijgo.15089}
}
EUVIMED